secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLENO THERAPEUTICS INC (SLNO)
CIK:        0001484565
Form:       8-K
Filed at:   2023-05-26T23:59:59+00:00
Accession:  0001193125-23-155448
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Soleno Therapeutics stockholders approve all six proposals at 2023 annual meeting
--------------------------------------------------------------------------------

- Elected Ernest Mario and Birgitte Volck as Class II directors with ~64.8% and ~66.7% of votes cast, respectively.
- Ratified Marcum LLP as independent auditor for fiscal 2023 (5,977,682 for, 113,718 against).
- Advisory say-on-pay approved (4,019,358 for, 111,424 against); board accepted three-year frequency.
- Approved amended 2014 Equity Incentive Plan (3,874,198 for, 254,424 against).
- Approved issuance of shares upon exercise of warrants from May 8, 2023 private placement (4,003,720 for, 132,021 against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484565/000119312523155448/0001193125-23-155448-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484565/000119312523155448/d515984d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-155448

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer